How do psychiatric patients perceive the side effects of their medications
暂无分享,去创建一个
[1] B. Psaty,et al. Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis , 2004 .
[2] J F Gallelli,et al. Development of a Questionnaire for Detecting Potential Adverse Drug Reactions , 1992, The Annals of pharmacotherapy.
[3] David Khayat,et al. Changing patient perceptions of the side effects of cancer chemotherapy , 2002, Cancer.
[4] J. Kalachnik. Measuring side effects of psychopharmacologic medication in individuals with mental retardation and developmental disabilities , 1999 .
[5] W. Fleischhacker,et al. Compliance with antipsychotic drug treatment: influence of side effects. , 1994, Acta psychiatrica Scandinavica. Supplementum.
[6] I. Edwards,et al. Adverse drug reactions: definitions, diagnosis, and management , 2000, The Lancet.
[7] M. Rawlins,et al. Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions. , 2000, Journal of hepatology.
[8] P. Weiden,et al. An Innovative Approach to Clinical Communication in Schizophrenia: The Approaches to Schizophrenia Communication Checklists , 2001, CNS Spectrums.
[9] K. Michels. Problems Assessing Nonserious Adverse Drug Reactions: Antidepressant Drug Therapy and Sexual Dysfunction , 1999, Pharmacotherapy.
[10] E. Lindström,et al. Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia. Clinical validation of a self-rating version of the UKU Side Effect Rating Scale (UKU-SERS-Pat) , 2001, Nordic journal of psychiatry.
[11] M. Pirmohamed,et al. Reporting of adverse drug reactions by nurses , 2003, The Lancet.
[12] Joshua Borus,et al. Adverse drug events in ambulatory care. , 2003, The New England journal of medicine.
[13] J. Rabkin,et al. General versus systematic inquiry about emergent clinical events with SAFTEE: implications for clinical research. , 1992, Journal of clinical psychopharmacology.
[14] R. Bentall,et al. A Self-Rating Scale for Measuring Neuroleptic Side-Effects , 1995, British Journal of Psychiatry.
[15] Mph Dr. Syed Rizwanuddin Ahmad MD. Adverse drug event monitoring at the food and drug administration , 2007, Journal of General Internal Medicine.
[16] S. Jordan,et al. Monitoring adverse drug reactions: scales, profiles, and checklists. , 2004, International nursing review.
[17] G. Simpson,et al. A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS , 1970, Acta psychiatrica Scandinavica. Supplementum.
[18] Yusuke Tanigawara,et al. MICROMEDEX® Healthcare Series , 2004 .
[19] Sheena Derry,et al. BMC Clinical Pharmacology BioMed Central BMC 1 2001, Clinical Pharmacology , 2001 .
[20] O. Andersson. Registration of side effects by means of a questionnaire. , 2009, Acta medica Scandinavica. Supplementum.
[21] S. Bentzen,et al. The need for adverse effects reporting standards in oncology clinical trials. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] U. Ahlfors,et al. The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patients , 1987, Acta psychiatrica Scandinavica. Supplementum.
[23] G. Klerman,et al. The effects of antihypertensive therapy on the quality of life. , 1986, The New England journal of medicine.
[24] John P A Ioannidis,et al. Improving Safety Reporting from Randomised Trials , 2002, Drug safety.
[25] S Benjamin,et al. How to examine patients using the Abnormal Involuntary Movement Scale. , 1988, Hospital & community psychiatry.